X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
1st-line treatment (1) 1
acute kidney injury - chemically induced (1) 1
anemia - chemically induced (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
central nervous system neoplasms - diagnostic imaging (1) 1
central nervous system neoplasms - mortality (1) 1
central nervous system neoplasms - therapy (1) 1
central-nervous-system (1) 1
chemical and drug induced liver injury - epidemiology (1) 1
combined modality therapy - adverse effects (1) 1
combined modality therapy - methods (1) 1
comparative effectiveness research (1) 1
cytarabine - adverse effects (1) 1
cytarabine - therapeutic use (1) 1
death, sudden - epidemiology (1) 1
denmark (1) 1
dexamethasone - therapeutic use (1) 1
disease-free survival (1) 1
female (1) 1
follow-up (1) 1
follow-up studies (1) 1
gastrointestinal diseases - chemically induced (1) 1
germany (1) 1
guidelines (1) 1
heart injuries - chemically induced (1) 1
hematology (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation - adverse effects (1) 1
hematopoietic stem cell transplantation - methods (1) 1
high-dose chemotherapy (1) 1
humans (1) 1
hyperglycemia - chemically induced (1) 1
index medicus (1) 1
induction chemotherapy - adverse effects (1) 1
induction chemotherapy - methods (1) 1
infection - chemically induced (1) 1
intraocular lymphoma - diagnostic imaging (1) 1
intraocular lymphoma - therapy (1) 1
italy (1) 1
journal article (1) 1
kaplan-meier estimate (1) 1
lymphoma, b-cell - diagnostic imaging (1) 1
lymphoma, b-cell - mortality (1) 1
lymphoma, b-cell - therapy (1) 1
magnetic resonance imaging (1) 1
male (1) 1
methotrexate - adverse effects (1) 1
methotrexate - therapeutic use (1) 1
middle aged (1) 1
mucositis - chemically induced (1) 1
neurotoxicity syndromes - epidemiology (1) 1
neutropenia - chemically induced (1) 1
non-hodgkins-lymphoma (1) 1
optic nerve neoplasms - diagnostic imaging (1) 1
optic nerve neoplasms - therapy (1) 1
poisoning - epidemiology (1) 1
radiotherapy, adjuvant - adverse effects (1) 1
radiotherapy, adjuvant - methods (1) 1
remission induction - methods (1) 1
response criteria (1) 1
rituximab - adverse effects (1) 1
rituximab - therapeutic use (1) 1
stem-cell transplantation (1) 1
stroke - chemically induced (1) 1
switzerland (1) 1
thiotepa - adverse effects (1) 1
thiotepa - therapeutic use (1) 1
thrombocytopenia - chemically induced (1) 1
thrombosis - chemically induced (1) 1
transplantation conditioning - adverse effects (1) 1
transplantation conditioning - methods (1) 1
transplantation, autologous - adverse effects (1) 1
treatment outcome (1) 1
united kingdom (1) 1
whole-brain radiotherapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.